Prasad Kulkarni on the Covishield vaccine
Listen now
Description
Prasad Kulkarni, Medical Director of the Serum Institute of India, discusses his recent phase 2/3 trial on the Covishield vaccine published in EClinicalMedicine, as well as its implications for COVID vaccine development in general. 
More Episodes
Bridget Chukwudile and Dr Laura Nellums join Rachel Kerslake and Ben Burwood to talk about their recent systematic review on Antimicrobial resistance among migrants in Europe.Read the full...
Published 11/01/24
Dr Zoe Kourtzi joins Sundus Ahmad and Hannah Linne to talk about her recent publication on the development of an AI-guided marker for early dementia prediction in real-world clinical settings.Read the full...
Published 10/04/24